Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Operating Income (2024 - 2026)

Beta Bionics' Operating Income history spans 3 years, with the latest figure at -$24.3 million for Q1 2026.

  • On a quarterly basis, Operating Income fell 30.2% to -$24.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$77.3 million, a 42.01% decrease, with the full-year FY2025 number at -$71.7 million, down 58.41% from a year prior.
  • Operating Income hit -$24.3 million in Q1 2026 for Beta Bionics, down from -$16.1 million in the prior quarter.
  • Over the last five years, Operating Income for BBNX hit a ceiling of -$9.5 million in Q1 2024 and a floor of -$24.3 million in Q1 2026.
  • Historically, Operating Income has averaged -$15.7 million across 3 years, with a median of -$16.1 million in 2025.
  • The widest YoY moves for Operating Income: up 23.68% in 2025, down 97.21% in 2025.
  • Tracing BBNX's Operating Income over 3 years: stood at -$13.0 million in 2024, then fell by 23.68% to -$16.1 million in 2025, then tumbled by 50.53% to -$24.3 million in 2026.
  • Business Quant data shows Operating Income for BBNX at -$24.3 million in Q1 2026, -$16.1 million in Q4 2025, and -$17.0 million in Q3 2025.